SCHEMBL3536738

SCHEMBL3536738

CCCCN(CCCC)CC(O)CCC

nearest known ligand 0.47

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 2/20 0.47
MAPK1 P28482 1/20 0.47
TDP1 Q9NUW8 1/20 0.47
MEN1 O00255 1/20 0.44
KMT2A Q03164 1/20 0.44
POLB P06746 1/20 0.37
NPSR1 Q6W5P4 1/20 0.37
PLA2G1B P04054 1/20 0.36
PLA2G2A P14555 1/20 0.36
CA12 O43570 2/20 0.35
CA1 P00915 2/20 0.35
CA9 Q16790 2/20 0.35
L3MBTL1 Q9Y468 1/20 0.35
HSF1 Q00613 1/20 0.34
MMP1 P03956 1/20 0.33
MMP2 P08253 1/20 0.33
MMP3 P08254 1/20 0.33
MMP8 P22894 1/20 0.33
GPR84 Q9NQS5 4/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11699005 0.96 KDM4E (0.45) KDM4EMAPK1TDP1MEN1KMT2A
SCHEMBL29966470 0.88 KDM4E (0.51) KDM4EMAPK1TDP1MEN1KMT2A
SCHEMBL11611967 0.87 GPR84 (0.47) KDM4EMAPK1TDP1MEN1KMT2A
SCHEMBL3531190 0.87 GPR84 (0.47) KDM4EMAPK1TDP1MEN1KMT2A
SCHEMBL3540872 0.87 GPR84 (0.47) KDM4EMAPK1TDP1MEN1KMT2A
SCHEMBL8641180 0.87 PLA2G1B (0.42) KDM4EMAPK1TDP1PLA2G1BPLA2G2A
SCHEMBL25587775 0.86 L3MBTL1 (0.39) KDM4EMAPK1TDP1MEN1KMT2A
SCHEMBL3536789 0.86 ALDH1A1 (0.39) KDM4EMAPK1TDP1MEN1KMT2A
SCHEMBL18567086 0.84 KDM4E (0.49) KDM4EMAPK1TDP1MEN1KMT2A
SCHEMBL474323 0.84 KDM4E (0.49) KDM4EMAPK1TDP1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1812401-B1 METHOD FOR PRODUCING PERYLENE-3,4-DICARBOXYLIC ACID IMIDES BASF SE (DE) 2015-06-24 EP disclosed
US-7799920-B2 Method for producing perylene-3,4-dicarboxylic acid imides BASF AKTIENGESELLSCHAFT (DE) 2010-09-21 US disclosed
US-20080114170-A1 Method For Producing Perylene-3,4-Dicarboxylic Acid Imides BASF AKTIENGESELLSCHAFT (DE) 2008-05-15 US disclosed
EP-1812401-A1 METHOD FOR PRODUCING PERYLENE-3,4-DICARBOXYLIC ACID IMIDES BASF AKTIENGESELLSCHAFT (DE) 2007-08-01 EP disclosed
WO-2006050860-A1 METHOD FOR PRODUCING PERYLENE-3,4-DICARBOXYLIC ACID IMIDES BASF AKTIENGESELLSCHAFT (DE) 2006-05-18 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080114170-A1 Method For Producing Perylene-3,4-Dicarboxylic Acid Imides CPNE4, IDH3A, RPL23A KDM4E 2062/4885MAPK1 1731/4885TDP1 3884/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.